专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

31. 发明申请

US20100287443A1 PROCESSOR BASED SYSTEM HAVING ECC BASED CHECK AND ACCESS VALIDATION INFORMATION MEANS 有权
标题翻译：基于ECC的基于处理器的系统检查和访问验证信息手段
公开(公告)号：US20100287443A1
公开(公告)日：2010-11-11
申请号：US12811454
申请日：2008-01-16
申请人： Michael Rohleder , Gary Hay , Stephan Mueller , Manfred Thanner
发明人： Michael Rohleder , Gary Hay , Stephan Mueller , Manfred Thanner
IPC分类号： H03M13/09 , G06F13/40
CPC分类号： G06F11/1645 , G06F11/10 , G06F11/1654 , G06F2201/845
摘要： A system comprises a first master element; and at least one shared communication element arranged to operably couple the first master element to at least one slave element. The system further comprises at least one validation element located on at least one further validation path located between the first master element and the at least one slave element, wherein the at least one validation element is arranged to validate at least one of: at least one access request by the first master element; and a response to an access request from the at least one slave element.
摘要翻译：一种系统包括第一主元件; 以及布置成将第一主元件可操作地耦合到至少一个从属元件的至少一个共享通信元件。所述系统还包括位于位于所述第一主元件和所述至少一个从属元件之间的至少一个另外的验证路径上的至少一个验证元件，其中所述至少一个验证元件被布置成验证以下至少一个：至少一个由第一个主元素访问请求; 以及对来自所述至少一个从属单元的访问请求的响应。

32. 发明申请

US20090256162A1 Method for Producing Semi-Insulating Resistivity in High Purity Silicon Carbide Crystals 审中-公开
标题翻译：在高纯度碳化硅晶体中生产半绝缘电阻率的方法
公开(公告)号：US20090256162A1
公开(公告)日：2009-10-15
申请号：US12490615
申请日：2009-06-24
申请人： Jason Ronald Jenny , David Phillip Malta , Hudson McDonald Hobgood , Stephan Mueller , Valeri F. Tsvetkov
发明人： Jason Ronald Jenny , David Phillip Malta , Hudson McDonald Hobgood , Stephan Mueller , Valeri F. Tsvetkov
IPC分类号： H01L29/24 , C01B31/36 , H01B1/04 , C30B25/02
CPC分类号： H01L21/324 , C30B29/36 , C30B33/00
摘要： A method is disclosed for producing high quality semi-insulating silicon carbide crystals in the absence of relevant amounts of deep level trapping elements. The invention includes the steps of heating a silicon carbide crystal having a first concentration of point defects to a temperature that thermodynamically increases the number of point defects and resulting states in the crystal, and then cooling the heated crystal at a sufficiently rapid rate to maintain an increased concentration of point defects in the cooled crystal.
摘要翻译：公开了一种在没有相关量的深层捕获元件的情况下生产高质量半绝缘碳化硅晶体的方法。本发明包括以下步骤：将具有第一点缺陷浓度的碳化硅晶体加热到热力学上增加晶体中的点缺陷和结果状态的温度，然后以足够快的速率冷却加热的晶体，以维持冷却晶体中点缺陷的浓度增加。

33. 发明授权

US07364617B2 Seed and seedholder combinations for high quality growth of large silicon carbide single crystals 有权
标题翻译：种子和种子组合，用于高质量生长的大型碳化硅单晶
公开(公告)号：US07364617B2
公开(公告)日：2008-04-29
申请号：US11671015
申请日：2007-02-05
申请人： Stephan Mueller , Adrian Powell , Valeri F. Tsvetkov
发明人： Stephan Mueller , Adrian Powell , Valeri F. Tsvetkov
IPC分类号： C30B11/14
CPC分类号： C30B23/005 , C30B29/36 , Y10S117/911 , Y10T117/10 , Y10T117/1032
摘要： A silicon carbide seeded sublimation method is disclosed. The method includes the steps of nucleating growth on a seed crystal growth face that is between about 1° and 10° off-axis from the (0001) plane of the seed crystal while establishing a thermal gradient between the seed crystal and a source composition that is substantially perpendicular to the basal plane of the off-axis crystal.
摘要翻译：公开了一种碳化硅种子升华方法。该方法包括以下步骤：在籽晶的（0001）面离轴离开约1°至10°之间的晶种生长面上成长生长，同时在晶种和源组成之间建立热梯度，基本上垂直于离轴晶体的基面。

34. 发明申请

US20070157874A1 Seed and Seedholder Combinations for High Quality Growth of Large Silicon Carbide single Crystals 有权
标题翻译：种子和种子组合，用于大型碳化硅单晶的高质量生长
公开(公告)号：US20070157874A1
公开(公告)日：2007-07-12
申请号：US11671015
申请日：2007-02-05
申请人： Stephan Mueller , Adrian Powell , Valeri Tsvetkov
发明人： Stephan Mueller , Adrian Powell , Valeri Tsvetkov
IPC分类号： C30B25/00 , C30B23/00 , C30B28/12
CPC分类号： C30B23/005 , C30B29/36 , Y10S117/911 , Y10T117/10 , Y10T117/1032
摘要： A silicon carbide seeded sublimation method is disclosed. The method includes the steps of nucleating growth on a seed crystal growth face that is between about 1° and 10° off-axis from the (0001) plane of the seed crystal while establishing a thermal gradient between the seed crystal and a source composition that is substantially perpendicular to the basal plane of the off-axis crystal.
摘要翻译：公开了一种碳化硅种子升华方法。该方法包括以下步骤：在籽晶的（0001）面离轴离开约1°至10°之间的晶种生长面上成长生长，同时在晶种和源组成之间建立热梯度，基本上垂直于离轴晶体的基面。

35. 发明申请

US20070111981A1 New (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compounds 审中-公开
标题翻译：具有MCH拮抗活性的新（杂）芳基化合物和包含这些化合物的药物
公开(公告)号：US20070111981A1
公开(公告)日：2007-05-17
申请号：US11552836
申请日：2006-10-25
申请人： Gerald Roth , Stephan Mueller , Thorsten Lehmann-Lintz , Dirk Stenkamp , Philipp Lustenberger , Joerg Kley , Klaus Rudolf , Armin Heckel , Marcus Schindler , Leo Thomas , Ralf Lotz
发明人： Gerald Roth , Stephan Mueller , Thorsten Lehmann-Lintz , Dirk Stenkamp , Philipp Lustenberger , Joerg Kley , Klaus Rudolf , Armin Heckel , Marcus Schindler , Leo Thomas , Ralf Lotz
IPC分类号： A61K31/541 , A61K31/5377 , A61K31/496 , A61K31/454
CPC分类号： C07D237/08
摘要： The present invention relates to (hetero)aryl compounds of general formula I wherein the groups and radicals A, B, Q, W, X, Y, Z, R1, R2, R4a, R4b, R5a, R5b, have the meanings given in claim 1. Moreover the invention relates to pharmaceutical compositions containing at least one compound according to the invention. By virtue of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.
摘要翻译：本发明涉及通式I的（杂）芳基化合物，其中基团A，B，Q，W，X，Y，Z，R 1，R 2， R 4，R 4a，R 4b，R 5a，R 5b，R 5b具有权利要求1中给出的含义。此外，本发明涉及含有至少一种本发明化合物的药物组合物。由于它们的MCH受体拮抗活性，本发明的药物组合物适用于治疗代谢紊乱和/或进食障碍，特别是肥胖症，食欲过剩，厌食症，食欲过盛和糖尿病。

36. 发明授权

US07192482B2 Seed and seedholder combinations for high quality growth of large silicon carbide single crystals 有权
标题翻译：种子和种子组合，用于高质量生长的大型碳化硅单晶
公开(公告)号：US07192482B2
公开(公告)日：2007-03-20
申请号：US10915095
申请日：2004-08-10
申请人： Stephan Mueller , Adrian Powell , Valeri F. Tsvetkov
发明人： Stephan Mueller , Adrian Powell , Valeri F. Tsvetkov
IPC分类号： C30B25/12
CPC分类号： C30B23/005 , C30B29/36 , Y10S117/911 , Y10T117/10 , Y10T117/1032
摘要： A silicon carbide seeded sublimation growth system and associated method are disclosed. The system includes a crucible, a silicon carbide source composition in the crucible, a seed holder in the crucible, a silicon carbide seed crystal on the seed holder, means for creating a major thermal gradient in the crucible that defines a major growth direction between the source composition and the seed crystal for encouraging vapor transport between the source composition and the seed crystal, and the seed crystal being positioned on the seed holder with the macroscopic growth surface of the seed crystal forming an angle of between about 70° and 89.5° degrees relative to the major thermal gradient and the major growth direction and with the crystallographic orientation of the seed crystal having the c-axis of the crystal forming an angle with the major thermal gradient of between about 0° and 2°.
摘要翻译：公开了一种碳化硅种子升华生长系统及其相关方法。该系统包括坩埚，坩埚中的碳化硅源组合物，坩埚中的种子保持器，种子保持器上的碳化硅晶种，用于在坩埚中产生主要的热梯度的装置，其限定了坩埚中的主要生长方向源组合物和晶种，用于促进源组合物和晶种之间的蒸气传输，并且晶种位于种子保持器上，其中晶种的宏观生长表面形成约70°至89.5°之间的角度相对于主要的热梯度和主要的生长方向以及具有晶体的c轴的晶种的晶体取向与主要的热梯度在约0°和2°之间形成一个角度。

37. 发明申请

US20070049581A1 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions 有权
标题翻译：选择的CGRP拮抗剂，其制备方法及其作为药物组合物的用途
公开(公告)号：US20070049581A1
公开(公告)日：2007-03-01
申请号：US11462511
申请日：2006-08-04
申请人： Stephan Mueller , Klaus Rudolf , Philipp Lustenberger , Gerhard Schaenzle , Marco Santagostino , Dirk Stenkamp , Kirsten Arndt , Henri Doods
发明人： Stephan Mueller , Klaus Rudolf , Philipp Lustenberger , Gerhard Schaenzle , Marco Santagostino , Dirk Stenkamp , Kirsten Arndt , Henri Doods
IPC分类号： A61K31/5513 , A61K31/517 , A61K31/454 , C07D403/02
CPC分类号： C07D401/14 , C07D405/14
摘要： The present invention relates to the CGRP antagonists of general formula I wherein R1, R2, R3 and R4 are as defined in claim 1, the tautomers, the isomers, the diastereomers, the enantiomers, the hydrates thereof, the mixtures thereof and the salts thereof and the hydrates of the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, as well as those compounds of general formula I wherein one or more hydrogen atoms are replaced by deuterium, pharmaceutical compositions containing these compounds, their use and processes for preparing them.
摘要翻译：本发明涉及通式I的CGRP拮抗剂，其中R 1，R 2，R 3和R 4， SUP>如权利要求1所定义，互变异构体，异构体，非对映异构体，对映异构体，其水合物，其混合物及其盐及其盐的水合物，特别是其与无机或有机物的生理学上可接受的盐酸或碱，以及其中一个或多个氢原子被氘代替的通式I的那些化合物，含有这些化合物的药物组合物，其用途和制备方法。

38. 发明申请

US20060252931A1 New CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions 有权
标题翻译：新的CGRP拮抗剂，其制备方法及其作为药物组合物的用途
公开(公告)号：US20060252931A1
公开(公告)日：2006-11-09
申请号：US11277177
申请日：2006-03-22
申请人： Stephan Mueller , Klaus Rudolf , Philipp Lustenberger , Dirk Stenkamp , Marco Santagostino , Fabio Paleari , Gerhard Schaenzle , Kirsten Arndt , Henri Doods
发明人： Stephan Mueller , Klaus Rudolf , Philipp Lustenberger , Dirk Stenkamp , Marco Santagostino , Fabio Paleari , Gerhard Schaenzle , Kirsten Arndt , Henri Doods
IPC分类号： C07D498/02 , C07D491/10 , C07D487/10 , C07D403/02
CPC分类号： C07D405/12 , C07D405/14 , C07D413/14
摘要： The present invention relates to the CGRP-antagonists of general formula I wherein R1, R2, R3, R4 and X are defined as in claim 1, the tautomers, the isomers, the diastereomers, the enantiomers, the hydrates, mixtures and salts thereof and the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, as well as those compounds of general formula I in which one or more hydrogen atoms are replaced by deuterium, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof.
摘要翻译：本发明涉及通式I的CGRP拮抗剂，其中R 1，R 2，R 3，R 4， X和X如权利要求1中所定义，互变异构体，异构体，非对映异构体，对映体，水合物，其混合物和盐以及盐的水合物，特别是其与无机或有机酸的生理上可接受的盐的水合物或碱，以及其中一个或多个氢原子被氘代替的通式I的那些化合物，含有这些化合物的药物组合物，其用途及其制备方法。

39. 发明申请

US20050282857A1 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions 审中-公开
标题翻译：选择的CGRP拮抗剂，其制备方法及其作为药物组合物的用途
公开(公告)号：US20050282857A1
公开(公告)日：2005-12-22
申请号：US11107195
申请日：2005-04-15
申请人： Klaus Rudolf , Stephan Mueller , Philipp Lustenberger , Dirk Stenkamp , Gerhard Schaenzle , Kirsten Arndt , Henri Doods
发明人： Klaus Rudolf , Stephan Mueller , Philipp Lustenberger , Dirk Stenkamp , Gerhard Schaenzle , Kirsten Arndt , Henri Doods
IPC分类号： A61K31/445 , C07D211/32 , C07D401/04 , C07D401/12 , C07D451/04 , C07D453/02 , C07D487/04 , C07D487/08
CPC分类号： C07D451/04 , C07D401/04 , C07D401/12 , C07D453/02 , C07D487/04 , C07D487/08
摘要： The present invention relates to the CGRP antagonists of general formula wherein A, X and R1 to R3 are defined as in claim 1, the tautomers, the diastereomers, the enantiomers, the hydrates thereof, the mixtures thereof and the salts thereof and the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof.
摘要翻译：本发明涉及通式C的CGRP拮抗剂，其中A，X和R 1至R 3如权利要求1所定义，互变异构体，非对映异构体，对映异构体，其水合物，其混合物及其盐以及盐，特别是其与无机或有机酸的生理学上可接受的盐的水合物，含有这些化合物的药物组合物，其用途及其制备方法。

40. 发明申请

US20050256099A1 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions 有权
标题翻译：选择的CGRP拮抗剂，其制备方法及其作为药物组合物的用途
公开(公告)号：US20050256099A1
公开(公告)日：2005-11-17
申请号：US11109968
申请日：2005-04-20
申请人： Stephan Mueller , Klaus Rudolf , Philipp Lustenberger , Dirk Stenkamp , Marco Santagostino , Fabio Paleari , Gerhard Schaenzle , Kirsten Arndt , Henri Doods
发明人： Stephan Mueller , Klaus Rudolf , Philipp Lustenberger , Dirk Stenkamp , Marco Santagostino , Fabio Paleari , Gerhard Schaenzle , Kirsten Arndt , Henri Doods
IPC分类号： A61K31/454 , A61K31/541 , A61K31/554 , C07D401/14 , C07D405/14 , C07D413/14 , C07D417/04 , C07D471/04 , C07D495/04 , C07D498/10
CPC分类号： C07D401/14 , C07D405/14 , C07D413/14 , C07D471/04 , C07D495/04
摘要： The present invention relates to the CGRP antagonists of general formula wherein A, X, Q and R1 to R3 are defined as in claim 1, the tautomers, the isomers, the diastereomers, the enantiomers, the hydrates, mixtures and salts thereof and the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids, pharmaceutical compositions containing these compounds, their use and processes for preparing them.
摘要翻译：本发明涉及通式C的CGRP拮抗剂，其中A，X，Q和R 1至R 3定义如权利要求1所述，互变异构体，异构体，非对映异构体，对映异构体，水合物，其混合物和盐以及盐，特别是其与无机或有机酸的生理学上可接受的盐的水合物，含有这些化合物的药物组合物，其用途和制备方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式